Bharat Parenterals Ltd Share Price

1,525
(0.59%)
Jul 23, 2024|03:40:00 PM

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Equities

Futures

Option

  • Open1,550
  • Day's High1,560
  • 52 Wk High1,824.7
  • Prev. Close1,516.05
  • Day's Low1,503
  • 52 Wk Low417.05
  • Turnover (lac)10.85
  • P/E38.69
  • Face Value10
  • Book Value369.83
  • EPS39.18
  • Mkt. Cap (Cr.)880.64
  • Div. Yield0.07
No Records Found

Bharat Parenterals Ltd KEY RATIOS

Sector

Pharmaceuticals

Open

1,550

Prev. Close

1,516.05

Turnover(Lac.)

10.85

Day's High

1,560

Day's Low

1,503

52 Week's High

1,824.7

52 Week's Low

417.05

Book Value

369.83

Face Value

10

Mkt Cap (₹ Cr.)

880.64

P/E

38.69

EPS

39.18

Divi. Yield

0.07

Bharat Parenterals Ltd Corporate Action

10 Jun 2024

12:00 AM

BookCloser

arrow

10 Jun 2024

12:00 AM

AGM

Announcement Date: 10 Jun, 2024

arrow

6 Jun 2024

12:00 AM

Board Meeting

Agenda : Audited Result

arrow

29 Apr 2024

12:00 AM

EGM

arrow

22 May 2024

12:00 AM

Dividend

Dividend Amount: 1

Record Date: 25 Jun, 2024

arrow

Bharat Parenterals Ltd NEWS AND UPDATE

No data found

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Bharat Parenterals Ltd SHAREHOLDING SNAPSHOT

23 Jul, 2024|04:31 PM
  • Foreign Promoter
  • Indian Promoter
  • Institutions
  • Non Institutions
  • Custodies

Promoter- 65.35%

Foreign: 0.00%

Indian: 65.35%

Non-Promoter- 0.00%

Institutions: 0.00%

Non-Institutions: 23.83%

Custodian: 10.80%

Share Price

Bharat Parenterals Ltd FINANCIALS

Balance Sheet

Profit & Loss

Cash Flow

Ratios

Results

Loading...
Y/e 31 Mar( In .Cr)Mar-2024Mar-2023Mar-2022Mar-2021

Equity Capital

5.82

5.77

5.77

5.73

Preference Capital

0

0

0

0

Reserves

207.79

185.29

160.38

138.21

Net Worth

213.61

191.06

166.15

143.94

Minority Interest

View Balance Sheet
Loading...
Y/e 31 Mar( In .Cr)Mar-2021Mar-2020Mar-2018Mar-2017

Revenue

203.66

226.32

136.32

111.22

yoy growth (%)

-10.01

66.01

22.56

-7.1

Raw materials

-134.03

-147.23

-87.98

-79.26

As % of sales

65.8

65.05

64.53

71.26

Employee costs

-14.38

-14.1

-12.36

-11.05

View Profit & Loss
Loading...
Y/e 31 Mar( In .Cr)Mar-2021Mar-2020Mar-2018Mar-2017

Profit before tax

27.01

34.95

13.77

7.96

Depreciation

-6.02

-5.88

-5.57

-5.79

Tax paid

-6.8

-8.65

-3.67

-0.58

Working capital

-3.24

29.95

17.25

-4.15

Other operating items

View Cash Flow
Loading...
Y/e 31 MarMar-2021Mar-2020Mar-2018Mar-2017

Growth matrix (%)

Revenue growth

-10.01

66.01

22.56

-7.1

Op profit growth

-16.81

127.66

89.81

-32.25

EBIT growth

-22.44

143.4

65.89

-18.1

Net profit growth

-23.15

160.4

36.86

14.35

View Ratios
Particulars (Rupees in Crores.)Mar-2024Mar-2023Mar-2022Mar-2021Mar-2020

Gross Sales

257.36

217.98

212.01

204.64

228.18

Excise Duty

0

0

0

0

0

Net Sales

257.36

217.98

212.01

204.64

228.18

Other Operating Income

0

0

0

0

0

Other Income

8.59

11.74

7.78

8.67

11.48

Bharat Parenterals Ltd Peer Comparison

Company Name
LTP
(₹)
P/E
(%)
Mkt.Cap
(₹Cr.)
NP Qtr
(₹Cr.)
Div.Yield
(%)
Sales Qtr
(₹.Cr)
Book Value
(₹)

Sun Pharmaceuticals Industries Ltd

SUNPHARMA

1,587.9

124.833,80,990.4867.60.855,536.9998.75

Divis Laboratories Ltd

DIVISLAB

4,534.75

76.421,20,383.365310.662,259507.93

Cipla Ltd

CIPLA

1,489.7

32.381,20,295.961,038.40.573,444.92346.41

Zydus Lifesciences Ltd

ZYDUSLIFE

1,154.4

33.791,16,159.651,405.20.263,172.6156.19

Dr Reddys Laboratories Ltd

DRREDDY

6,769.25

26.361,12,931.21,034.80.595,081.81,458.96

Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.

MORE ABOUT Bharat Parenterals Ltd

Management

Register Office

Registrar Office

Managing Director

Bharat Kumar R Desai

Executive Director

Hemang Jayendrabhai Shah

Non Executive Director

Shaileshkumar Ghabhawala

Independent Director

Zankhana Sheth

Independent Director

Mukesh Patel

Non Executive Director

Sanjay Shah

Company Sec. & Compli. Officer

Krutika Bhattbhatt

Registered Office


Tel: -

Website: -

Email: -

Registrar Office


Tel: -

Website: -

Email: -

Summary

Bharat Parenterals Ltd. was incorporated on Sep.92 in Gujarat and promoted by Ramesh Desai and Bharat Desai. The Company is engaged in the business of manufacturing drugs, pharmaceutical formulations and ayurvedic products at its plant in Baroda. It has set-up a fully integrated and modern plant as per WHO standards at Haripura near Baroda for manufacturing pharmaceutical formulations, life saving drugs, parenterals and antibiotics.In 2016, Varenyam Healthcare Private Limited was incorporated as wholly owned subsidiary company effective 09 July, 2016. Innoxel Lifesciences was incorporated as wholly owned subsidiary company effective 16th October, 2020. Varenyam Biolifesciences got incorporated as wholly owned subsidiary company effective 28th June, 2022.
Read More

Company FAQs

What is the Bharat Parenterals Ltd share price today?

Down Arrow

The Bharat Parenterals Ltd shares price on BOMBAY STOCK EXCHANGE (BSE) is Rs.₹1525 today.

What is the Market Cap of Bharat Parenterals Ltd?

Down Arrow

Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Bharat Parenterals Ltd is ₹880.64 Cr. as of 23 Jul ‘24

What is the PE and PB ratio of Bharat Parenterals Ltd?

Down Arrow

The PE and PB ratios of Bharat Parenterals Ltd is 38.69 and 4.10 as of 23 Jul ‘24

What is the 52 Week High and Low of Bharat Parenterals Ltd?

Down Arrow

The 52-week high/low is the highest and lowest price at which a Bharat Parenterals Ltd stock has traded during that given time period (similar to 1 year) and is considered as a technical indicator. The 52 week high and low of Bharat Parenterals Ltd is ₹417.05 and ₹1824.7 as of 23 Jul ‘24

What is the CAGR of Bharat Parenterals Ltd?

Down Arrow

Bharat Parenterals Ltd's CAGR for 5 Years at 54.31%, 3 Years at 58.90%, 1 Year at 254.59%, 6 Month at 93.87%, 3 Month at -0.28% and 1 Month at 4.99%.

What is the shareholding pattern of Bharat Parenterals Ltd?

Down Arrow

The shareholding pattern of Bharat Parenterals Ltd is as follows:
Promoters - 73.27 %
Institutions - 0.01 %
Public - 26.73 %

Knowledge Centerplus
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Securities Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Knowledge Centerplus

Follow us on

facebooktwitterrssyoutubeinstagramlinkedin

2024, IIFL Securities Ltd. All Rights Reserved

ATTENTION INVESTORS
  • Prevent Unauthorized Transactions in your demat / trading account Update your Mobile Number/ email Id with your stock broker / Depository Participant. Receive information of your transactions directly from Exchanges on your mobile / email at the end of day and alerts on your registered mobile for all debits and other important transactions in your demat account directly from NSDL/ CDSL on the same day." - Issued in the interest of investors.
  • KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.
  • No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."

www.indiainfoline.com is part of the IIFL Group, a leading financial services player and a diversified NBFC. The site provides comprehensive and real time information on Indian corporates, sectors, financial markets and economy. On the site we feature industry and political leaders, entrepreneurs, and trend setters. The research, personal finance and market tutorial sections are widely followed by students, academia, corporates and investors among others.

RISK DISCLOSURE ON DERIVATIVES
  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to Rs. 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Copyright © IIFL Securities Ltd. All rights Reserved.

Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248

plus
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.